The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that
protect against severe disease and preferably drive herd immunity. Regulators in numerous …

An often-stated public health comment is that “vaccination is a victim of its own success.”
While the scientific and medical consensus on the benefits of vaccination is clear and …

Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient
immunization coverage to end the global pandemic, yet few studies have investigated …

On an individual level, one dimension of trust that may be common to COVID-19 and other
vaccines is the overall reluctance to obtain vaccinations due to fear of serious side effects …

Abstract As of March 31, 2021, Israel had administered 116 doses of vaccine for COVID-19
per 100 population (of any age)–far more than any other OECD country. It was also ahead of …

Introduction: Acceptance of COVID-19 vaccines is critical to personal health, protecting
vulnerable populations, reopening socio-economic life, and achieving population health and …

Misinformation and disinformation regarding COVID-19 and vaccination against it may be
contributing to vaccine hesitancy. Social media outlets have reportedly made efforts to limit …

With SARS-CoV-2 vaccines under development, research is needed to assess intention to
vaccinate. We conducted a survey (N= 3,159) with US adults in May 2020 assessing SARS …

Vaccine hesitancy, defined as the refusal, delay, or acceptance with doubts about vaccine
usefulness and safety [1], is recognized by the World Health Organization as one of the 10 …

The COVID-19 vaccine rollout has had various degrees of success in different countries.
Achieving high levels of vaccine coverage is key to responding to and mitigating the impact …